prikaz prve stranice dokumenta Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma
  Download
PDF 863.42 KB
Scientific paper - Preliminary note / Short communication
Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma
Acta Dermato-Venereologica, 102 (2022); adv00650. https://doi.org/10.2340/actadv.v102.1433
Batinac, Tanja; Hlača, Nika; Simetić, Luka; Valković, Frane; Peternel, Sandra; Prpić-Massari, Larisa

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Batinac, T., Hlača, N., Simetić, L., Valković, F., Peternel, S. & Prpić Massari, L. (2022). Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma. Acta Dermato-Venereologica, 102.. doi: 10.2340/actadv.v102.1433

Batinac, Tanja, et al. "Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma." Acta Dermato-Venereologica, vol. 102, 2022. https://doi.org/10.2340/actadv.v102.1433

Batinac, Tanja, Nika Hlača, Luka Simetić, Frane Valković, Sandra Peternel and Larisa Prpić Massari. "Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma." Acta Dermato-Venereologica 102 (2022). https://doi.org/10.2340/actadv.v102.1433

Batinac, T., et al. (2022) 'Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma', Acta Dermato-Venereologica, 102. doi: 10.2340/actadv.v102.1433

Batinac T, Hlača N, Simetić L, Valković F, Peternel S, Prpić Massari L. Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma. Acta Dermato-Venereologica [Internet]. 2022 February 22 [cited 2024 November 26];102. doi: 10.2340/actadv.v102.1433

T. Batinac, N. Hlača, L. Simetić, F. Valković, S. Peternel and L. Prpić Massari, "Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma", Acta Dermato-Venereologica, vol. 102, February 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:920000. [Accessed: 26 November 2024]

Metadata
Title (english)Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma
AuthorTanja Batinac
AuthorNika Hlača
AuthorLuka Simetić
AuthorFrane Valković
AuthorSandra Peternel
AuthorLarisa Prpić-Massari
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Dermatovenerology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Dermatovenerology
Keywords (english)
Languageenglish
Publication typeScientific paper - Preliminary note / Short communication
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleActa Dermato-Venereologica
Numberingvol. 102, adv00650
p-ISSN0001-5555
e-ISSN1651-2057
DOIhttps://doi.org/10.2340/actadv.v102.1433
URN:NBNurn:nbn:hr:184:920000
Publication2022-02-22
Document URLhttps://medicaljournalssweden.se/actadv/article/view/1433
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2022-03-21 17:13:33